Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven Springmeyer
Biodesix, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- University of Colorado
Aurora, Colorado, United States
- Beth Israel Deaconess
Boston, Connecticut, United States
- Massachusetts General Hospital
Boston, Connecticut, United States
- Medstar
Washington D.C., District of Columbia, United States
- Indiana University
Indianapolis, Indiana, United States
- the Johns Hopkins University
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- the Washington University
St Louis, Missouri, United States
- Mount Sinai Health System
New York, New York, United States
- Northwell Health
New York, New York, United States
- the University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Southeastern Research Center
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- the Ohio State University
Coulmbus, Ohio, United States
- the Oregon Clinic
Portland, Oregon, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Ralph H Johnson Va Medical Center
Charleston, South Carolina, United States
- Prisma Health
Greenville, South Carolina, United States
- University of Texas Southwestern
Dallas, Texas, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2020
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2026
- Last update posted
- 19 Sept 2025
- Registered enrollment
- 2,000
- Registry id
- NCT04171492
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.